Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PepsiCo
PEP
|
+$192M |
| 2 |
Johnson & Johnson
JNJ
|
+$179M |
| 3 |
EMC
EMC CORPORATION
EMC
|
+$177M |
| 4 |
Chubb
CB
|
+$153M |
| 5 |
Eli Lilly
LLY
|
+$142M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$470M |
| 2 |
PRE
PARTNERRE LTD
PRE
|
+$186M |
| 3 |
Comcast
CMCSA
|
+$179M |
| 4 |
Pfizer
PFE
|
+$168M |
| 5 |
Gilead Sciences
GILD
|
+$144M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.92% |
| 2 | Healthcare | 11.63% |
| 3 | Technology | 11.35% |
| 4 | Industrials | 10.55% |
| 5 | Consumer Staples | 10.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRRA
2976
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $305K | ﹤0.01% |
1,133
+158
| +16% | +$50.5K |
|
2977
Gogo Inc
GOGO
$383M
| $303K | ﹤0.01% |
27,500
-9,700
| -26% | -$123K |
|
|
BPTH
2978
DELISTED
Bio-Path Holdings Inc
BPTH
| $302K | ﹤0.01% |
29
+9
| +45% | +$58.3K |
|
|
DATE
2979
DELISTED
JIAYUAN COM INTL LTD SPON ADR (CYM)
DATE
| $302K | ﹤0.01% |
40,600
-473,133
| -92% | -$3.46M |
|
|
ICA
2980
DELISTED
EMPRESAS ICA, S.A. DE C.V. ADS (EA REPTG 4 ORD PART CERT)
ICA
| $297K | ﹤0.01% |
309,400
+26,100
| +9% | +$23.1K |
|
2981
InfuSystem Holdings
INFU
$244M
| $294K | ﹤0.01% |
83,600
+69,000
| +473% | +$218K |
|
2982
Intel
INTC
$527B
| $294K | ﹤0.01% |
9,100
-797,894
| -99% | -$24.5M |
|
2983
Identive
INVE
$63.4M
| $294K | ﹤0.01% |
136,060
+17,100
| +14% | +$34K |
|
2984
United Bankshares
UBSI
$6.66B
| $294K | ﹤0.01% |
+8,000
| New | +$281K |
|
2985
Colony Bankcorp
CBAN
$467M
| $292K | ﹤0.01% |
31,800
+3,100
| +11% | +$28.6K |
|
|
SUMR
2986
DELISTED
Summer Infant, Inc.
SUMR
| $292K | ﹤0.01% |
18,544
+788
| +4% | +$13.1K |
|
|
SRNE
2987
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $290K | ﹤0.01% |
53,890
+24,700
| +85% | +$144K |
|
2988
Ring Energy
REI
$354M
| $289K | ﹤0.01% |
+57,300
| New | +$285K |
|
|
ATAXZ
2989
DELISTED
AMERICA FIRST TAX EXEMT INV LP
ATAXZ
| $289K | ﹤0.01% |
55,100
-117,900
| -68% | -$618K |
|
|
ELP
2990
DELISTED
Companhia Paranaense de Energia (COPEL)
ELP
| $288K | ﹤0.01% |
+91,000
| New | +$223K |
|
2991
1-800-Flowers.com
FLWS
$262M
| $288K | ﹤0.01% |
36,600
-112,510
| -75% | -$843K |
|
2992
INNOVATE Corp
VATE
$105M
| $286K | ﹤0.01% |
7,490
+2,690
| +56% | +$103K |
|
|
VBTX
2993
DELISTED
Veritex Holdings
VBTX
| $286K | ﹤0.01% |
19,700
+1,500
| +8% | +$21.3K |
|
2994
EVI Industries
EVI
$206M
| $283K | ﹤0.01% |
87,200
+1,000
| +1% | +$3.51K |
|
|
VTTI
2995
DELISTED
VTTI Energy Partners LP
VTTI
| $278K | ﹤0.01% |
+15,000
| New | +$264K |
|
|
ENFY
2996
DELISTED
Enlightify Inc
ENFY
| $276K | ﹤0.01% |
17,017
+2,242
| +15% | +$34.8K |
|
|
CTRL
2997
DELISTED
Control4 Corporation
CTRL
| $275K | ﹤0.01% |
+34,500
| New | +$256K |
|
|
IRG
2998
DELISTED
Ignite Restaurant Group, Inc.
IRG
| $275K | ﹤0.01% |
84,800
+15,200
| +22% | +$51.3K |
|
|
RELV
2999
DELISTED
Reliv International Inc
RELV
| $274K | ﹤0.01% |
50,357
+214
| +0.4% | +$1.24K |
|
|
PWE
3000
DELISTED
Penn West Energy Petroleum Ltd
PWE
| $273K | ﹤0.01% |
294,103
+173,605
| +144% | +$148K |
|
Similar funds
Jim Simons's Q1 2016 Portfolio in Review
As of Q1 2016, Jim Simons held 3,753 positions worth $52.6B, up 15% from $45.9B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.31B of net new capital in Q1 2016, opening 498 new positions and adding to 2,018 existing holdings. Its largest new stake was EMC CORPORATION: 7,000,400 shares worth $187M.
By sector, the portfolio is most concentrated in Financials at 12% of assets, up from 11% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Pfizer, an estimated $168M trimmed.
- Jim Simons's largest Q1 2016 buy was EMC CORPORATION: 7,000,400 shares worth $187M.
- Jim Simons added most to PepsiCo in Q1 2016, an estimated $192M increase.
- Jim Simons's biggest Q1 2016 reduction was Pfizer, cutting an estimated $168M.
- Jim Simons fully exited Apple in Q1 2016, selling an estimated $470M.
- Jim Simons's ten largest holdings make up 7.9% of its $52.6B portfolio in Q1 2016.
- Jim Simons opened 498 new positions and closed 403 in Q1 2016.
- Jim Simons's portfolio value rose 15% quarter-over-quarter to $52.6B.
Based on Renaissance Technologies's 13F filing for Q1 2016, filed 13 May 2016.